This year, MediPaCe was honoured to co-facilitate the patient-centric sampling interest group’s (PCSIG’s) workshop “Incorporating PCS into Multicentre Clinical Trials“
But what is patient centric sampling or PCS?
Patient centric sampling is an approach for obtaining high quality biological samples (e.g. blood, plasma, urine, etc) from people at any time and in any location. These samples are routinely used to assist in the diagnosis and treatment of disease. Think your normal blood test for lipid levels or for HBA1c and you get the idea. But, instead of needing to take an afternoon off work to queue these samples can be delivered in the comfort of your own home or at a local pharmacy.
PCS brings the potential for more democratised and accessible healthcare for all – especially those most vulnerable and hard to reach communities. It is a major step forward in sampling approaches and, critically, in improving patient’s experience of the process.
It’s incredible that such a collaborative group, from a wide range of backgrounds, capabilities, and sectors came together to try to create a roadmap for how to incorporate PCS into clinical trials – a cornerstone for optimisation of decentralised and hybrid studies.
The clue is in the name – this provides an option for a patient-centric approach to sampling. Further, the involvement of patients in the approach is essential to ensure engagement and the provision of high-quality, timely data to support decision-making and care. If patient advocates, patients and PCS experts work together, we can create something truly transformative.
We look forward to sharing the roadmap and recommendations to share the steps for routine implementation in a clinical trial setting and how we involve patients themselves to co-create an optimal solution.

Want to learn more about PCS and the field of patient involvement? Check out our list below of some useful references and reading lists.
Patient centric sampling
- PCSIG What is PCS.,
- Patient Centric Blood Sampling and Quantitative Analysis (a reference close to MediPaCe’s heart as we authored a chapter and collaborated with many amazing other authors)
- Maass KF, Barfield MD, Ito M, et al. Leveraging patient-centric sampling for clinical drug development and decentralized clinical trials: Promise to reality. Clin Transl Sci.2022;15(12):2785-2795. doi:10.1111/cts.13411
- Dubé K, Eskaf S, Hastie E, et al. Preliminary acceptability of a home‐based peripheral blood collection device for viral load testing in the context of analytical treatment interruptions in HIV cure trials: results from a Nationwide survey in the United S
- Van Norman GA. Decentralized clinical trials: the future of medical product development?. JACC Basic to Transl Sci. 2021;6(4):384‐387. doi: 10.1016/j.jacbts.2021.01.011
Patient involvement and Patient Experience Data (PED) expectations